Drugs that contain Levoketoconazole
1. Recorlev patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10098877 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(1 year, 8 months from now) | |
| US9918984 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(1 year, 8 months from now) | |
| US10517868 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(1 year, 8 months from now) | |
| US10835530 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(1 year, 8 months from now) | |
| US11478471 | STRONGBRIDGE | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan, 2026
(1 year, 8 months from now) | |
| US11278547 | STRONGBRIDGE | Methods of treating disease with levoketoconazole |
Mar, 2040
(15 years from now) | |
| US11020393 | STRONGBRIDGE | Methods of treating disease with levoketoconazole |
Mar, 2040
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-385) | Dec 30, 2028 |
Market Authorisation Date: 30 December, 2021
Treatment: Treatment of endogenous hypercortisolemia in patients with cushing’s syndrome for whom surgery is not an option or has not been curative; During levoketoconazole dosage titration for the treatment of ...
Dosage: TABLET;ORAL
More Information on Dosage
RECORLEV family patents
